MicroRNA-124 mediates the cholinergic anti-inflammatory action through inhibiting the production of pro-inflammatory cytokines
The vagus nerve can control inflammatory response through a 'cholinergic anti-inflammatory pathway', which is mediated by the α7-nicotinic acetylcholine receptor (α7nAChR) on macrophages. However, the intracellular mechanisms that link a7nAChR activation and pro-inflammatory cytokine production rema...
Uloženo v:
| Vydáno v: | Cell research Ročník 23; číslo 11; s. 1270 - 1283 |
|---|---|
| Hlavní autoři: | , , , , , , |
| Médium: | Journal Article |
| Jazyk: | angličtina |
| Vydáno: |
London
Nature Publishing Group UK
01.11.2013
Nature Publishing Group |
| Témata: | |
| ISSN: | 1001-0602, 1748-7838, 1748-7838 |
| On-line přístup: | Získat plný text |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|
| Abstract | The vagus nerve can control inflammatory response through a 'cholinergic anti-inflammatory pathway', which is mediated by the α7-nicotinic acetylcholine receptor (α7nAChR) on macrophages. However, the intracellular mechanisms that link a7nAChR activation and pro-inflammatory cytokine production remain not well understood. In this study, we found that miR-124 is upregulated by cholinergic agonists in LPS-exposed cells and mice. Utilizing miR-124 mimic and siRNA knockdown, we demonstrated that miR-124 is a critical mediator for the cholinergic anti-inflammatory action. Furthermore, our data indicated that miR-124 modulates LPS-induced cytokine production by targeting signal transducer and activator of transcription 3 (STAT3) to decrease IL-6 production and TNF-o converting enzyme (TACE) to reduce TNF-α release. These results also indicate that miR-124 is a potential therapeutic target for the treatment of inflammatory diseases. |
|---|---|
| AbstractList | The vagus nerve can control inflammatory response through a 'cholinergic anti-inflammatory pathway', which is mediated by the α7-nicotinic acetylcholine receptor (α7nAChR) on macrophages. However, the intracellular mechanisms that link α7nAChR activation and pro-inflammatory cytokine production remain not well understood. In this study, we found that miR-124 is upregulated by cholinergic agonists in LPS-exposed cells and mice. Utilizing miR-124 mimic and siRNA knockdown, we demonstrated that miR-124 is a critical mediator for the cholinergic anti-inflammatory action. Furthermore, our data indicated that miR-124 modulates LPS-induced cytokine production by targeting signal transducer and activator of transcription 3 (STAT3) to decrease IL-6 production and TNF-α converting enzyme (TACE) to reduce TNF-α release. These results also indicate that miR-124 is a potential therapeutic target for the treatment of inflammatory diseases. The vagus nerve can control inflammatory response through a 'cholinergic anti-inflammatory pathway', which is mediated by the α7-nicotinic acetylcholine receptor (α7nAChR) on macrophages. However, the intracellular mechanisms that link a7nAChR activation and pro-inflammatory cytokine production remain not well understood. In this study, we found that miR-124 is upregulated by cholinergic agonists in LPS-exposed cells and mice. Utilizing miR-124 mimic and siRNA knockdown, we demonstrated that miR-124 is a critical mediator for the cholinergic anti-inflammatory action. Furthermore, our data indicated that miR-124 modulates LPS-induced cytokine production by targeting signal transducer and activator of transcription 3 (STAT3) to decrease IL-6 production and TNF-o converting enzyme (TACE) to reduce TNF-α release. These results also indicate that miR-124 is a potential therapeutic target for the treatment of inflammatory diseases. The vagus nerve can control inflammatory response through a 'cholinergic anti-inflammatory pathway', which is mediated by the alpha 7-nicotinic acetylcholine receptor ( alpha 7nAChR) on macrophages. However, the intracellular mechanisms that link alpha 7nAChR activation and pro-inflammatory cytokine production remain not well understood. In this study, we found that miR-124 is upregulated by cholinergic agonists in LPS-exposed cells and mice. Utilizing miR-124 mimic and siRNA knockdown, we demonstrated that miR-124 is a critical mediator for the cholinergic anti-inflammatory action. Furthermore, our data indicated that miR-124 modulates LPS-induced cytokine production by targeting signal transducer and activator of transcription 3 (STAT3) to decrease IL-6 production and TNF- alpha converting enzyme (TACE) to reduce TNF- alpha release. These results also indicate that miR-124 is a potential therapeutic target for the treatment of inflammatory diseases. The vagus nerve can control inflammatory response through a 'cholinergic anti-inflammatory pathway', which is mediated by the α7-nicotinic acetylcholine receptor (α7nAChR) on macrophages. However, the intracellular mechanisms that link α7nAChR activation and pro-inflammatory cytokine production remain not well understood. In this study, we found that miR-124 is upregulated by cholinergic agonists in LPS-exposed cells and mice. Utilizing miR-124 mimic and siRNA knockdown, we demonstrated that miR-124 is a critical mediator for the cholinergic anti-inflammatory action. Furthermore, our data indicated that miR-124 modulates LPS-induced cytokine production by targeting signal transducer and activator of transcription 3 (STAT3) to decrease IL-6 production and TNF-α converting enzyme (TACE) to reduce TNF-α release. These results also indicate that miR-124 is a potential therapeutic target for the treatment of inflammatory diseases.The vagus nerve can control inflammatory response through a 'cholinergic anti-inflammatory pathway', which is mediated by the α7-nicotinic acetylcholine receptor (α7nAChR) on macrophages. However, the intracellular mechanisms that link α7nAChR activation and pro-inflammatory cytokine production remain not well understood. In this study, we found that miR-124 is upregulated by cholinergic agonists in LPS-exposed cells and mice. Utilizing miR-124 mimic and siRNA knockdown, we demonstrated that miR-124 is a critical mediator for the cholinergic anti-inflammatory action. Furthermore, our data indicated that miR-124 modulates LPS-induced cytokine production by targeting signal transducer and activator of transcription 3 (STAT3) to decrease IL-6 production and TNF-α converting enzyme (TACE) to reduce TNF-α release. These results also indicate that miR-124 is a potential therapeutic target for the treatment of inflammatory diseases. |
| Author | Yang Sun Qi Li Huan Gui Dong-Ping Xu Yi-LiYang Ding-Feng Su Xia Liu |
| AuthorAffiliation | Department of Pharmacology, School of Pharmacy, Second Military Medical University, Shanghai 200433, China Cancer and Developmental Biology Laboratory, National Cancer Institute, National Institutes of Health, Frederick, MD 21702, USA |
| Author_xml | – sequence: 1 givenname: Yang surname: Sun fullname: Sun, Yang organization: Department of Pharmacology, School of Pharmacy, Second Military Medical University – sequence: 2 givenname: Qi surname: Li fullname: Li, Qi organization: Department of Pharmacology, School of Pharmacy, Second Military Medical University – sequence: 3 givenname: Huan surname: Gui fullname: Gui, Huan organization: Department of Pharmacology, School of Pharmacy, Second Military Medical University – sequence: 4 givenname: Dong-Ping surname: Xu fullname: Xu, Dong-Ping organization: Department of Pharmacology, School of Pharmacy, Second Military Medical University – sequence: 5 givenname: Yi-Li surname: Yang fullname: Yang, Yi-Li email: yiliyang@mail.nih.gov organization: Cancer and Developmental Biology Laboratory, National Cancer Institute, National Institutes of Health – sequence: 6 givenname: Ding-Feng surname: Su fullname: Su, Ding-Feng email: dfsu2008@gmail.com organization: Department of Pharmacology, School of Pharmacy, Second Military Medical University – sequence: 7 givenname: Xia surname: Liu fullname: Liu, Xia email: lxflying@aliyun.com organization: Department of Pharmacology, School of Pharmacy, Second Military Medical University |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/23979021$$D View this record in MEDLINE/PubMed |
| BookMark | eNqNkk1vFSEUhiemxn7oyr0Z48ZE58oBBoZNk6bxK6maGF0ThmFmqHPhFhiTu_G3y3hvm7bpwhUQnvfJgXOOiwPnnSmK54BWgEjzTocVRkBWAOxRcQScNhVvSHOQ9whBhRjCh8VxjJcI4ZrW8KQ4xERwgTAcFX--WB38969nFWBark1nVTKxTKMp9egn60wYrC6VS7ayrp_Ueq2SD9tS6WS9y2Dw8zCW1o22tcm64V92E3w37wjfL6e7Yb1N_ld2x6fF415N0TzbryfFzw_vf5x_qi6-ffx8fnZR6ZpDqhTvuTG0boWGDmNkRI87AqCZYaI10CuDGtbpugWiasZEvu2wYkbUgiiByUlxuvNu5jY_UhuXgprkJti1ClvplZV3b5wd5eB_S9IArynNgtd7QfBXs4lJrm3UZpqUM36OEiijNSKIwH-gVOAG5-Zk9NU99NLPweWfWKgGU8TxInxxu_ibqq-7mAHYAbmVMQbTS22TWn4_v8VOEpBcJkXqIJdJkXlScubNvcy19mH67Y6OmXKDCbcKfRB_uZeP3g1XOXFjp5wz0TBE_gKsatp1 |
| CitedBy_id | crossref_primary_10_1016_j_tcm_2019_10_011 crossref_primary_10_1371_journal_pone_0164207 crossref_primary_10_1371_journal_pone_0193609 crossref_primary_10_1038_srep37709 crossref_primary_10_1016_j_trsl_2017_10_004 crossref_primary_10_1016_j_intimp_2021_108262 crossref_primary_10_1016_j_biopha_2020_110736 crossref_primary_10_1016_j_brainres_2015_08_029 crossref_primary_10_1097_SHK_0000000000000604 crossref_primary_10_1155_2014_283525 crossref_primary_10_1007_s00284_024_03977_2 crossref_primary_10_1016_j_jneuroim_2016_04_014 crossref_primary_10_1186_s12950_025_00443_z crossref_primary_10_1165_rcmb_2016_0270OC crossref_primary_10_1007_s00705_015_2351_0 crossref_primary_10_1038_s41598_018_35254_1 crossref_primary_10_1242_dev_170670 crossref_primary_10_1016_j_intimp_2016_01_009 crossref_primary_10_1016_j_neuroscience_2016_12_017 crossref_primary_10_1016_j_neulet_2018_07_022 crossref_primary_10_1016_j_drudis_2020_12_019 crossref_primary_10_3389_fncel_2015_00193 crossref_primary_10_1111_jvh_12284 crossref_primary_10_1016_j_abb_2021_108806 crossref_primary_10_1080_17501911_2025_2548762 crossref_primary_10_1134_S1062359023604780 crossref_primary_10_1016_j_brainres_2017_02_018 crossref_primary_10_1038_s41392_019_0061_x crossref_primary_10_1186_s13054_016_1555_3 crossref_primary_10_1007_s12035_017_0584_5 crossref_primary_10_1016_j_jconrel_2016_06_005 crossref_primary_10_3389_fimmu_2020_00235 crossref_primary_10_1007_s40291_022_00598_y crossref_primary_10_1007_s00441_015_2183_y crossref_primary_10_1016_j_expneurol_2020_113382 crossref_primary_10_1371_journal_pone_0254657 crossref_primary_10_3389_fimmu_2021_669566 crossref_primary_10_1007_s43032_023_01204_0 crossref_primary_10_1016_j_jneuroim_2019_04_012 crossref_primary_10_1002_smll_202107534 crossref_primary_10_3389_fimmu_2021_798713 crossref_primary_10_1002_adfm_202305558 crossref_primary_10_3892_ijmm_2016_2613 crossref_primary_10_1016_j_autrev_2024_103739 crossref_primary_10_1097_IN9_0000000000000027 crossref_primary_10_1007_s00109_016_1473_5 crossref_primary_10_1155_2021_9059601 crossref_primary_10_3389_fimmu_2025_1565068 crossref_primary_10_3389_fncel_2024_1365448 crossref_primary_10_3892_ijo_2023_5594 crossref_primary_10_1002_rmv_70026 crossref_primary_10_1038_s41598_021_89605_6 crossref_primary_10_1016_j_pneurobio_2017_03_004 crossref_primary_10_1186_s12974_018_1053_4 crossref_primary_10_1371_journal_pone_0160743 crossref_primary_10_1186_s12882_024_03688_7 crossref_primary_10_1016_j_bbrc_2017_03_106 crossref_primary_10_1016_j_diagmicrobio_2023_116053 crossref_primary_10_1002_mds_27928 crossref_primary_10_1007_s10571_025_01578_6 crossref_primary_10_1016_j_intimp_2025_115334 crossref_primary_10_1038_cddis_2016_426 crossref_primary_10_1016_j_nano_2015_10_011 crossref_primary_10_1007_s40520_019_01359_4 crossref_primary_10_1186_s40360_024_00749_3 crossref_primary_10_1016_j_ibmb_2018_11_004 crossref_primary_10_1016_j_molmed_2017_10_006 crossref_primary_10_1155_2022_1885066 crossref_primary_10_1016_j_scitotenv_2022_158777 crossref_primary_10_1136_annrheumdis_2022_222228 crossref_primary_10_1093_cid_ciab733 crossref_primary_10_1016_j_intimp_2021_107791 crossref_primary_10_1002_1873_3468_13789 crossref_primary_10_1097_MD_0000000000016470 crossref_primary_10_1016_j_ajog_2014_04_026 crossref_primary_10_1016_j_jaut_2022_102948 crossref_primary_10_2174_1381612826666200617163857 crossref_primary_10_3389_fcell_2021_732952 crossref_primary_10_1016_j_intimp_2024_113267 crossref_primary_10_1002_glia_23484 crossref_primary_10_1002_adfm_202401547 crossref_primary_10_1177_2058739218798463 crossref_primary_10_4049_jimmunol_1402088 crossref_primary_10_1007_s11064_021_03456_1 crossref_primary_10_31083_j_jin2202031 crossref_primary_10_1007_s10238_025_01588_0 crossref_primary_10_1016_j_arr_2024_102267 crossref_primary_10_3390_ijms21165801 crossref_primary_10_1016_j_phymed_2021_153745 crossref_primary_10_1002_cbf_3386 crossref_primary_10_1002_smll_202410162 crossref_primary_10_3389_fphar_2016_00290 crossref_primary_10_1016_j_ijpharm_2018_09_063 crossref_primary_10_1080_14728222_2018_1420166 crossref_primary_10_1158_0008_5472_CAN_20_1599 crossref_primary_10_3389_fncel_2017_00316 crossref_primary_10_1016_j_phrs_2023_106870 crossref_primary_10_3390_biomedicines11051417 crossref_primary_10_1038_s41598_018_37813_y crossref_primary_10_1007_s10753_018_0896_2 crossref_primary_10_1007_s00011_024_01987_1 crossref_primary_10_4049_jimmunol_2200192 crossref_primary_10_1007_s10753_024_02125_z crossref_primary_10_1111_joim_12611 crossref_primary_10_3389_fncel_2016_00125 crossref_primary_10_14309_ctg_0000000000000560 crossref_primary_10_1186_s12984_025_01700_1 crossref_primary_10_1136_annrheumdis_2014_206417 crossref_primary_10_1002_EXP_20230165 crossref_primary_10_2174_0113816128244442231018070639 crossref_primary_10_1002_oby_22298 crossref_primary_10_1111_jnc_15332 crossref_primary_10_1007_s11064_018_02714_z crossref_primary_10_1016_j_freeradbiomed_2021_06_007 crossref_primary_10_3389_fnagi_2018_00220 crossref_primary_10_55095_achot2022_059 crossref_primary_10_1155_2019_8243813 crossref_primary_10_1016_j_autrev_2025_103820 crossref_primary_10_1016_j_omtn_2020_05_012 crossref_primary_10_1080_08830185_2020_1779712 crossref_primary_10_3389_fimmu_2017_01452 crossref_primary_10_1186_s40635_016_0091_4 crossref_primary_10_1186_s13071_022_05164_3 crossref_primary_10_1016_j_omtn_2021_10_030 crossref_primary_10_1007_s10753_020_01396_6 crossref_primary_10_1016_j_micpath_2025_107914 crossref_primary_10_3389_fimmu_2020_590870 crossref_primary_10_1093_ibd_izad211 crossref_primary_10_3390_ijms222413427 crossref_primary_10_1016_j_xphs_2021_01_024 crossref_primary_10_1016_j_heliyon_2023_e21615 crossref_primary_10_1038_cr_2013_128 crossref_primary_10_1007_s11481_017_9760_7 crossref_primary_10_1021_acsbiomaterials_8b01510 crossref_primary_10_1177_1073858417721150 crossref_primary_10_1007_s11033_025_10288_7 crossref_primary_10_3389_fimmu_2018_01377 crossref_primary_10_1016_j_molmed_2016_07_001 crossref_primary_10_1007_s12035_017_0843_5 crossref_primary_10_1016_j_cej_2024_153407 crossref_primary_10_1124_pr_113_008581 crossref_primary_10_3109_01902148_2015_1004206 crossref_primary_10_3390_diseases9020029 crossref_primary_10_3390_ijms25179475 crossref_primary_10_1016_j_heliyon_2023_e22914 crossref_primary_10_1016_j_kint_2018_09_020 crossref_primary_10_1111_nmo_13288 crossref_primary_10_1080_15384101_2019_1638182 crossref_primary_10_1080_10717544_2020_1731861 crossref_primary_10_3390_ijms232415479 crossref_primary_10_1016_j_ejphar_2020_173315 crossref_primary_10_1007_s00018_022_04398_9 crossref_primary_10_1080_21691401_2019_1624559 crossref_primary_10_1038_srep18648 crossref_primary_10_3389_fimmu_2021_653344 crossref_primary_10_3390_pharmaceutics14020258 crossref_primary_10_3389_fcvm_2021_696413 crossref_primary_10_1007_s10157_024_02525_3 crossref_primary_10_1016_j_biopha_2018_05_076 crossref_primary_10_1007_s00011_022_01614_x crossref_primary_10_1371_journal_pone_0163645 crossref_primary_10_1016_j_neuroscience_2014_02_011 crossref_primary_10_1016_j_exger_2021_111578 crossref_primary_10_1038_aps_2016_16 crossref_primary_10_3390_molecules26040944 crossref_primary_10_1016_j_oooo_2016_03_018 crossref_primary_10_1016_j_ejphar_2018_06_028 crossref_primary_10_3389_fimmu_2019_00565 crossref_primary_10_1016_j_imlet_2016_08_006 crossref_primary_10_1038_npp_2016_167 crossref_primary_10_1021_acsbiomaterials_9b01550 crossref_primary_10_3390_separations10020076 crossref_primary_10_1159_000528502 crossref_primary_10_3390_ijms22094956 crossref_primary_10_3389_fimmu_2020_595342 crossref_primary_10_3390_ijms18091830 crossref_primary_10_1016_j_pharmthera_2017_05_002 crossref_primary_10_3389_fimmu_2016_00406 crossref_primary_10_3390_ijms23147611 crossref_primary_10_2478_jtim_2019_0011 crossref_primary_10_3389_fimmu_2022_1014013 crossref_primary_10_3389_fphar_2020_602999 |
| Cites_doi | 10.1084/jem.20052362 10.1523/JNEUROSCI.23-27-09024.2003 10.1038/nature01339 10.1038/nature08199 10.1093/intimm/dxr034 10.4049/jimmunol.179.5.2686 10.1146/annurev-immunol-020711-075013 10.4049/jimmunol.1100013 10.1038/nri2691 10.4161/cc.8.13.8816 10.1056/NEJMra021333 10.1038/nrd1797 10.1038/nm1124 10.1038/ni.1742 10.1042/bj20020588 10.1038/nature01320 10.1016/j.cyto.2008.07.006 10.1038/bjp.2008.185 10.1186/1476-4598-9-309 10.1038/nm.2266 10.1073/pnas.0803237105 10.1007/s13105-010-0050-6 10.1038/ni1229 10.4049/jimmunol.176.2.721 10.1517/13543784.9.1.103 10.1016/j.ccr.2009.02.015 10.1038/nature07201 10.1038/385733a0 10.1152/ajpcell.00160.2009 10.1146/annurev-immunol-020711-075015 10.1038/nature02738 10.1523/JNEUROSCI.2444-07.2007 10.1016/j.cell.2011.10.043 10.1126/science.1209985 10.1038/35013070 10.1007/s11095-010-0283-7 10.1007/s00395-013-0345-1 10.1002/art.23987 10.4049/jimmunol.0900707 10.1016/j.molimm.2009.02.018 10.1146/annurev.immunol.20.082401.104914 10.1002/stem.1154 10.1073/pnas.0709971104 10.1016/j.coph.2009.05.003 10.1002/eji.201040540 10.1186/1479-5876-9-129 10.1159/000329982 10.4049/jimmunol.179.8.5082 10.1038/nri802 10.1124/mol.105.018481 10.1177/000313481207800102 |
| ContentType | Journal Article |
| Copyright | The Author(s) 2013 Copyright Nature Publishing Group Nov 2013 Copyright © 2013 Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences 2013 Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences |
| Copyright_xml | – notice: The Author(s) 2013 – notice: Copyright Nature Publishing Group Nov 2013 – notice: Copyright © 2013 Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences 2013 Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences |
| DBID | 2RA 92L CQIGP W94 WU4 ~WA C6C AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7QO 7QP 7QR 7T5 7TK 7TM 7TO 7U9 7X7 7XB 88E 8FD 8FE 8FH 8FI 8FJ 8FK ABUWG AEUYN AFKRA AZQEC BBNVY BENPR BHPHI CCPQU DWQXO FR3 FYUFA GHDGH GNUQQ H94 HCIFZ K9. LK8 M0S M1P M7N M7P P64 PHGZM PHGZT PJZUB PKEHL PPXIY PQEST PQGLB PQQKQ PQUKI PRINS RC3 7X8 5PM |
| DOI | 10.1038/cr.2013.116 |
| DatabaseName | 维普期刊资源整合服务平台 中文科技期刊数据库-CALIS站点 维普中文期刊数据库 中文科技期刊数据库-自然科学 中文科技期刊数据库-自然科学-生物科学 中文科技期刊数据库- 镜像站点 Springer Nature OA Free Journals CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Biotechnology Research Abstracts Calcium & Calcified Tissue Abstracts Chemoreception Abstracts Immunology Abstracts Neurosciences Abstracts Nucleic Acids Abstracts Oncogenes and Growth Factors Abstracts Virology and AIDS Abstracts Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) Technology Research Database ProQuest SciTech Collection ProQuest Natural Science Collection Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest One Sustainability (subscription) ProQuest Central UK/Ireland ProQuest Central Essentials - QC Biological Science Collection ProQuest Central Natural Science Collection ProQuest One Community College ProQuest Central Engineering Research Database Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student AIDS and Cancer Research Abstracts SciTech Premium Collection ProQuest Health & Medical Complete (Alumni) Biological Sciences ProQuest Health & Medical Collection Medical Database Algology Mycology and Protozoology Abstracts (Microbiology C) Biological Science Database Biotechnology and BioEngineering Abstracts Proquest Central Premium ProQuest One Academic (New) ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Applied & Life Sciences ProQuest One Academic (retired) ProQuest One Academic UKI Edition ProQuest Central China Genetics Abstracts MEDLINE - Academic PubMed Central (Full Participant titles) |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) ProQuest Central Student Oncogenes and Growth Factors Abstracts ProQuest Central Essentials Nucleic Acids Abstracts SciTech Premium Collection ProQuest Central China ProQuest One Applied & Life Sciences ProQuest One Sustainability Health Research Premium Collection Natural Science Collection Health & Medical Research Collection Biological Science Collection Chemoreception Abstracts ProQuest Central (New) ProQuest Medical Library (Alumni) Virology and AIDS Abstracts ProQuest Biological Science Collection ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) Biological Science Database Neurosciences Abstracts ProQuest Hospital Collection (Alumni) Biotechnology and BioEngineering Abstracts ProQuest Health & Medical Complete ProQuest One Academic UKI Edition Engineering Research Database ProQuest One Academic Calcium & Calcified Tissue Abstracts ProQuest One Academic (New) Technology Research Database ProQuest One Academic Middle East (New) ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing ProQuest Natural Science Collection ProQuest Central ProQuest Health & Medical Research Collection Genetics Abstracts Biotechnology Research Abstracts Health and Medicine Complete (Alumni Edition) ProQuest Central Korea Algology Mycology and Protozoology Abstracts (Microbiology C) AIDS and Cancer Research Abstracts ProQuest SciTech Collection ProQuest Medical Library Immunology Abstracts ProQuest Central (Alumni) MEDLINE - Academic |
| DatabaseTitleList | AIDS and Cancer Research Abstracts MEDLINE ProQuest Central Student MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Biology |
| DocumentTitleAlternate | MicroRNA-124 mediates the cholinergic anti-inflammatory action through inhibiting the production of pro-inflammatory cytokines miR-124 and the cholinergic anti-inflammation |
| EISSN | 1748-7838 |
| EndPage | 1283 |
| ExternalDocumentID | PMC3817544 3116501101 23979021 10_1038_cr_2013_116 47769860 |
| Genre | Research Support, Non-U.S. Gov't Journal Article |
| GroupedDBID | --- -01 -0A -Q- -SA -S~ 0R~ 29B 2B. 2C. 2RA 2WC 36B 39C 3V. 4.4 406 53G 5GY 5VR 5XA 5XB 5XL 6J9 70F 7X7 88E 8FE 8FH 8FI 8FJ 92E 92I 92L 92M 92Q 93N 9D9 9DA AADWK AANZL AATNV AAWBL AAYFA AAYJO AAZLF ABAWZ ABGIJ ABJNI ABUWG ACAOD ACBMV ACBRV ACBYP ACGFO ACGFS ACIGE ACIWK ACKTT ACPRK ACRQY ACTTH ACVWB ACZOJ ADBBV ADFRT ADHDB ADMDM ADQMX ADYYL AEDAW AEFTE AEJRE AENEX AESKC AEVLU AEXYK AFKRA AFNRJ AFRAH AFSHS AFUIB AGEZK AGGBP AGHAI AHMBA AHSBF AILAN AJCLW AJDOV AJRNO ALFFA ALMA_UNASSIGNED_HOLDINGS AMRJV AMYLF AOIJS AXYYD BAWUL BBNVY BENPR BHPHI BKKNO BPHCQ BVXVI C1A CAG CAJEA CAJUS CCEZO CCPQU CCVFK CHBEP COF CQIGP CS3 CW9 DIK DNIVK DPUIP DU5 E3Z EBLON EBS EE. EIOEI EJD EMB EMOBN F5P FA0 FDQFY FERAY FIZPM FSGXE FYUFA GX1 HCIFZ HMCUK HYE HZ~ IWAJR JSO JUIAU JZLTJ KQ8 LK8 M1P M7P NAO NQJWS NXXTH NYICJ O9- OK1 P2P PQQKQ PROAC PSQYO Q-- Q-0 R-A RNS RNT RNTTT RPM RT1 S.. SNX SNYQT SOHCF SRMVM SV3 SWTZT T8Q TAOOD TBHMF TCJ TDRGL TGP TR2 U1F U1G U5A U5K UKHRP W94 WFFXF WU4 XSB ~88 ~WA AACDK AAHBH AASML AAXDM AAYZH ABAKF ABZZP ACMJI AEFQL AEMSY AEUYN AFBBN AGQEE AIGIU ALIPV C6C FIGPU LGEZI LOTEE NADUK ROL SOJ AAYXX ABBRH ABDBE ABFSG ABRTQ ACSTC AEZWR AFDZB AFFHD AFHIU AHWEU AIXLP ATHPR AYFIA CITATION PHGZM PHGZT PJZUB PPXIY PQGLB CGR CUY CVF ECM EIF NPM 7QO 7QP 7QR 7T5 7TK 7TM 7TO 7U9 7XB 8FD 8FK AZQEC DWQXO FR3 GNUQQ H94 K9. M7N P64 PKEHL PQEST PQUKI PRINS RC3 7X8 PUEGO 5PM |
| ID | FETCH-LOGICAL-c571t-a7f7ee45b9c1d220e9f2d311c6e69be1fae086dc5b13a56692d3d2a6e9593a923 |
| IEDL.DBID | M7P |
| ISICitedReferencesCount | 214 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000326683600009&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 1001-0602 1748-7838 |
| IngestDate | Tue Nov 04 01:53:44 EST 2025 Thu Oct 02 05:11:28 EDT 2025 Thu Nov 20 07:38:45 EST 2025 Sat Nov 29 14:28:39 EST 2025 Mon Jul 21 05:57:12 EDT 2025 Tue Nov 18 22:28:30 EST 2025 Sat Nov 29 05:46:52 EST 2025 Fri Feb 21 02:38:10 EST 2025 Wed Feb 14 10:38:19 EST 2024 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 11 |
| Keywords | macrophages septic shock α7nAChR cholinergic anti-inflammatory action STAT3 TACE micorRNA-124 |
| Language | English |
| License | https://creativecommons.org/licenses/by-nc-nd/3.0 This work is licensed under the Creative Commons Attribution-NonCommercial-No Derivative Works 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c571t-a7f7ee45b9c1d220e9f2d311c6e69be1fae086dc5b13a56692d3d2a6e9593a923 |
| Notes | The vagus nerve can control inflammatory response through a 'cholinergic anti-inflammatory pathway', which is mediated by the α7-nicotinic acetylcholine receptor (α7nAChR) on macrophages. However, the intracellular mechanisms that link a7nAChR activation and pro-inflammatory cytokine production remain not well understood. In this study, we found that miR-124 is upregulated by cholinergic agonists in LPS-exposed cells and mice. Utilizing miR-124 mimic and siRNA knockdown, we demonstrated that miR-124 is a critical mediator for the cholinergic anti-inflammatory action. Furthermore, our data indicated that miR-124 modulates LPS-induced cytokine production by targeting signal transducer and activator of transcription 3 (STAT3) to decrease IL-6 production and TNF-o converting enzyme (TACE) to reduce TNF-α release. These results also indicate that miR-124 is a potential therapeutic target for the treatment of inflammatory diseases. 31-1568/Q microRNA-124; cholinergic anti-inflammatory action; ct7nAChR; macrophages; septic shock; STAT3; TACE ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 ObjectType-Article-2 ObjectType-Feature-1 These two authors contributed equally to this work. |
| OpenAccessLink | https://pubmed.ncbi.nlm.nih.gov/PMC3817544 |
| PMID | 23979021 |
| PQID | 1448240721 |
| PQPubID | 536307 |
| PageCount | 14 |
| ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_3817544 proquest_miscellaneous_1464503031 proquest_miscellaneous_1449282100 proquest_journals_1448240721 pubmed_primary_23979021 crossref_citationtrail_10_1038_cr_2013_116 crossref_primary_10_1038_cr_2013_116 springer_journals_10_1038_cr_2013_116 chongqing_primary_47769860 |
| PublicationCentury | 2000 |
| PublicationDate | 2013-11-01 |
| PublicationDateYYYYMMDD | 2013-11-01 |
| PublicationDate_xml | – month: 11 year: 2013 text: 2013-11-01 day: 01 |
| PublicationDecade | 2010 |
| PublicationPlace | London |
| PublicationPlace_xml | – name: London – name: England |
| PublicationTitle | Cell research |
| PublicationTitleAbbrev | Cell Res |
| PublicationTitleAlternate | Cell Research |
| PublicationYear | 2013 |
| Publisher | Nature Publishing Group UK Nature Publishing Group |
| Publisher_xml | – name: Nature Publishing Group UK – name: Nature Publishing Group |
| References | Smookler, Mohammed, Kassiri, Duncan, Mak, Khokha (CR27) 2006; 176 Marrero, Bencherif, Lippiello, Lucas (CR9) 2011; 28 Fry (CR33) 2012; 78 Hotchkiss, Karl (CR29) 2003; 348 Hou, Wang, Lin (CR50) 2009; 183 Karginov, Conaco, Xuan (CR16) 2007; 104 Quinn, O'Neill (CR23) 2011; 23 Bitner, Bunnelle, Anderson (CR13) 2007; 27 Tili, Michaille, Cimino (CR22) 2007; 179 Samavati, Rastogi, Du, Huttemann, Fite, Franchi (CR43) 2009; 46 Lee, Lim, Sakong, Lee, Kim, Baek (CR44) 2006; 69 Feldmann (CR30) 2002; 2 Van Assche, Rutgeerts (CR31) 2000; 9 Waldburger, Boyle, Pavlov, Tracey, Firestein (CR19) 2008; 58 Webster, Tonelli, Sternberg (CR3) 2002; 20 O'Connell, Rao, Baltimore (CR17) 2012; 30 Borovikova, Ivanova, Zhang (CR4) 2000; 405 Huang, Shen, Zou, Wang, Tang, Zhang (CR15) 2011; 67 Rosas-Ballina, Ochani, Parrish (CR25) 2008; 105 Horiuchi, Kimura, Miyamoto (CR28) 2007; 179 Wessler, Kirkpatrick (CR11) 2008; 154 Wang, Chen, Zhang (CR51) 2009; 10 Zhao, He, Bi, Yu, Gil Wier, Zang (CR10) 2013; 108 Pena, Cai, Liu (CR42) 2010; 40 Yamamoto, Yamazaki, Uematsu (CR37) 2004; 430 Chatterjee, Al-Abed, Sherry, Metz (CR40) 2009; 297 Yu, Zhang, Kone (CR45) 2002; 367 Wang, Yu, Ochani (CR14) 2003; 421 Huston, Ochani, Rosas-Ballina (CR24) 2006; 203 Lakhan, Kirchgessner (CR35) 2011; 9 Lindenblatt, Schulze-Osthoff, Totzke (CR36) 2009; 8 Li, Zhou, Kolosov, Perelman (CR38) 2011; 27 de Jonge, van der Zanden, The (CR41) 2005; 6 Pena, Cai, Ramos, Vida, Deitch, Ulloa (CR7) 2011; 187 Ponomarev, Veremeyko, Barteneva, Krichevsky, Weiner (CR20) 2011; 17 Khiroug, Giniatullin, Klein, Fayuk, Yakel (CR12) 2003; 23 Suzuki, Yamagata, Sugimoto, Iwamoto, Kato, Miyazono (CR18) 2009; 460 Sims, Smith (CR32) 2010; 10 Lee, Herrmann, Deng (CR46) 2009; 15 Huang, Yeh, Lin (CR47) 2010; 9 Rosas-Ballina, Olofsson, Ochani (CR6) 2011; 334 Park, Baik, Cho, Kim, Lee, Han (CR39) 2008; 44 Hatziapostolou, Polytarchou, Aggelidou (CR49) 2011; 147 Tsitsiou, Lindsay (CR21) 2009; 9 Cai, Li, Wang (CR48) 2012; 30 Ulloa (CR5) 2005; 4 Moss, Jin, Milla (CR26) 1997; 385 Wang, Liao, Ochani (CR8) 2004; 10 Andersson, Tracey (CR34) 2012; 30 Medzhitov (CR1) 2008; 454 Nathan (CR2) 2002; 420 I Wessler (BFcr2013116_CR11) 2008; 154 Q Li (BFcr2013116_CR38) 2011; 27 JE Sims (BFcr2013116_CR32) 2010; 10 FV Karginov (BFcr2013116_CR16) 2007; 104 JM Waldburger (BFcr2013116_CR19) 2008; 58 Y Huang (BFcr2013116_CR15) 2011; 67 SY Park (BFcr2013116_CR39) 2008; 44 WJ de Jonge (BFcr2013116_CR41) 2005; 6 DS Smookler (BFcr2013116_CR27) 2006; 176 G Pena (BFcr2013116_CR42) 2010; 40 C Lee (BFcr2013116_CR44) 2006; 69 RM O'Connell (BFcr2013116_CR17) 2012; 30 PK Chatterjee (BFcr2013116_CR40) 2009; 297 K Horiuchi (BFcr2013116_CR28) 2007; 179 M Rosas-Ballina (BFcr2013116_CR6) 2011; 334 SR Quinn (BFcr2013116_CR23) 2011; 23 M Feldmann (BFcr2013116_CR30) 2002; 2 C Nathan (BFcr2013116_CR2) 2002; 420 ED Ponomarev (BFcr2013116_CR20) 2011; 17 R Medzhitov (BFcr2013116_CR1) 2008; 454 RS Hotchkiss (BFcr2013116_CR29) 2003; 348 M Rosas-Ballina (BFcr2013116_CR25) 2008; 105 G Pena (BFcr2013116_CR7) 2011; 187 H Wang (BFcr2013116_CR8) 2004; 10 MB Marrero (BFcr2013116_CR9) 2011; 28 M Yamamoto (BFcr2013116_CR37) 2004; 430 SE Lakhan (BFcr2013116_CR35) 2011; 9 M Zhao (BFcr2013116_CR10) 2013; 108 H Wang (BFcr2013116_CR14) 2003; 421 H Lee (BFcr2013116_CR46) 2009; 15 L Ulloa (BFcr2013116_CR5) 2005; 4 ML Moss (BFcr2013116_CR26) 1997; 385 DE Fry (BFcr2013116_CR33) 2012; 78 J Hou (BFcr2013116_CR50) 2009; 183 JM Huston (BFcr2013116_CR24) 2006; 203 B Cai (BFcr2013116_CR48) 2012; 30 M Hatziapostolou (BFcr2013116_CR49) 2011; 147 JI Webster (BFcr2013116_CR3) 2002; 20 L Samavati (BFcr2013116_CR43) 2009; 46 U Andersson (BFcr2013116_CR34) 2012; 30 Z Yu (BFcr2013116_CR45) 2002; 367 WL Huang (BFcr2013116_CR47) 2010; 9 C Wang (BFcr2013116_CR51) 2009; 10 E Tili (BFcr2013116_CR22) 2007; 179 RS Bitner (BFcr2013116_CR13) 2007; 27 LV Borovikova (BFcr2013116_CR4) 2000; 405 E Tsitsiou (BFcr2013116_CR21) 2009; 9 HI Suzuki (BFcr2013116_CR18) 2009; 460 L Khiroug (BFcr2013116_CR12) 2003; 23 G Van Assche (BFcr2013116_CR31) 2000; 9 C Lindenblatt (BFcr2013116_CR36) 2009; 8 12057007 - Biochem J. 2002 Oct 1;367(Pt 1):97-105 12490957 - Nature. 2002 Dec 19-26;420(6917):846-52 17911593 - J Immunol. 2007 Oct 15;179(8):5082-9 21810260 - J Transl Med. 2011;9:129 17898229 - J Neurosci. 2007 Sep 26;27(39):10578-87 16785311 - J Exp Med. 2006 Jul 10;203(7):1623-8 11861600 - Annu Rev Immunol. 2002;20:125-63 18975306 - Arthritis Rheum. 2008 Nov;58(11):3439-49 22696253 - Stem Cells. 2012 Aug;30(8):1746-55 21666060 - J Immunol. 2011 Jul 15;187(2):718-25 20081871 - Nat Rev Immunol. 2010 Feb;10(2):89-102 16393953 - J Immunol. 2006 Jan 15;176(2):721-5 19626115 - Nature. 2009 Jul 23;460(7254):529-33 22224773 - Annu Rev Immunol. 2012;30:295-312 11060664 - Expert Opin Investig Drugs. 2000 Jan;9(1):103-11 19345327 - Cancer Cell. 2009 Apr 7;15(4):283-93 20981514 - J Physiol Biochem. 2011 Mar;67(1):129-39 19299019 - Mol Immunol. 2009 May;46(8-9):1867-77 15241416 - Nature. 2004 Jul 8;430(6996):218-22 19502795 - Cell Cycle. 2009 Jul 1;8(13):2019-23 18650913 - Nature. 2008 Jul 24;454(7203):428-35 24018376 - Cell Res. 2013 Nov;23(11):1249-50 18669662 - Proc Natl Acad Sci U S A. 2008 Aug 5;105(31):11008-13 18042700 - Proc Natl Acad Sci U S A. 2007 Dec 4;104(49):19291-6 21921156 - Science. 2011 Oct 7;334(6052):98-101 19525145 - Curr Opin Pharmacol. 2009 Aug;9(4):514-20 18500366 - Br J Pharmacol. 2008 Aug;154(8):1558-71 16354768 - Mol Pharmacol. 2006 Mar;69(3):1041-7 19483718 - Nat Immunol. 2009 Jul;10(7):744-52 21691078 - Cell Physiol Biochem. 2011;27(5):605-12 21131957 - Nat Med. 2011 Jan;17(1):64-70 21122157 - Mol Cancer. 2010;9:309 12508119 - Nature. 2003 Jan 23;421(6921):384-8 18723372 - Cytokine. 2008 Oct;44(1):126-34 10839541 - Nature. 2000 May 25;405(6785):458-62 23519622 - Basic Res Cardiol. 2013 May;108(3):345 22153071 - Cell. 2011 Dec 9;147(6):1233-47 22224768 - Annu Rev Immunol. 2012;30:313-35 16025117 - Nat Immunol. 2005 Aug;6(8):844-51 20706987 - Eur J Immunol. 2010 Sep;40(9):2580-9 20859658 - Pharm Res. 2011 Feb;28(2):413-6 12033742 - Nat Rev Immunol. 2002 May;2(5):364-71 12519925 - N Engl J Med. 2003 Jan 9;348(2):138-50 15502843 - Nat Med. 2004 Nov;10(11):1216-21 19596990 - J Immunol. 2009 Aug 1;183(3):2150-8 19741199 - Am J Physiol Cell Physiol. 2009 Nov;297(5):C1294-306 17709479 - J Immunol. 2007 Sep 1;179(5):2686-9 21652514 - Int Immunol. 2011 Jul;23(7):421-5 14534236 - J Neurosci. 2003 Oct 8;23(27):9024-31 9034191 - Nature. 1997 Feb 20;385(6618):733-6 22273282 - Am Surg. 2012 Jan;78(1):1-8 16056392 - Nat Rev Drug Discov. 2005 Aug;4(8):673-84 |
| References_xml | – volume: 203 start-page: 1623 year: 2006 end-page: 1628 ident: CR24 article-title: Splenectomy inactivates the cholinergic antiinflammatory pathway during lethal endotoxemia and polymicrobial sepsis publication-title: J Exp Med doi: 10.1084/jem.20052362 – volume: 23 start-page: 9024 year: 2003 end-page: 9031 ident: CR12 article-title: Functional mapping and Ca2+ regulation of nicotinic acetylcholine receptor channels in rat hippocampal CA1 neurons publication-title: J Neurosci doi: 10.1523/JNEUROSCI.23-27-09024.2003 – volume: 421 start-page: 384 year: 2003 end-page: 388 ident: CR14 article-title: Nicotinic acetylcholine receptor alpha7 subunit is an essential regulator of inflammation publication-title: Nature doi: 10.1038/nature01339 – volume: 460 start-page: 529 year: 2009 end-page: 533 ident: CR18 article-title: Modulation of microRNA processing by p53 publication-title: Nature doi: 10.1038/nature08199 – volume: 23 start-page: 421 year: 2011 end-page: 425 ident: CR23 article-title: A trio of microRNAs that control Toll-like receptor signalling publication-title: Int Immunol doi: 10.1093/intimm/dxr034 – volume: 179 start-page: 2686 year: 2007 end-page: 2689 ident: CR28 article-title: Cutting edge: TNF-alpha-converting enzyme (TACE/ADAM17) inactivation in mouse myeloid cells prevents lethality from endotoxin shock publication-title: J Immunol doi: 10.4049/jimmunol.179.5.2686 – volume: 30 start-page: 295 year: 2012 end-page: 312 ident: CR17 article-title: MicroRNA regulation of inflammatory responses publication-title: Annu Rev Immunol doi: 10.1146/annurev-immunol-020711-075013 – volume: 187 start-page: 718 year: 2011 end-page: 725 ident: CR7 article-title: Cholinergic regulatory lymphocytes re-establish neuromodulation of innate immune responses in sepsis publication-title: J Immunol doi: 10.4049/jimmunol.1100013 – volume: 10 start-page: 89 year: 2010 end-page: 102 ident: CR32 article-title: The IL-1 family: regulators of immunity publication-title: Nat Rev Immunol doi: 10.1038/nri2691 – volume: 8 start-page: 2019 year: 2009 end-page: 2023 ident: CR36 article-title: Iκbζ expression is regulated by miR-124a publication-title: Cell Cycle doi: 10.4161/cc.8.13.8816 – volume: 348 start-page: 138 year: 2003 end-page: 150 ident: CR29 article-title: The pathophysiology and treatment of sepsis publication-title: N Engl J Med doi: 10.1056/NEJMra021333 – volume: 4 start-page: 673 year: 2005 end-page: 684 ident: CR5 article-title: The vagus nerve and the nicotinic anti-inflammatory pathway publication-title: Nat Rev Drug Discov doi: 10.1038/nrd1797 – volume: 10 start-page: 1216 year: 2004 end-page: 1221 ident: CR8 article-title: Cholinergic agonists inhibit HMGB1 release and improve survival in experimental sepsis publication-title: Nat Med doi: 10.1038/nm1124 – volume: 10 start-page: 744 year: 2009 end-page: 752 ident: CR51 article-title: The E3 ubiquitin ligase Nrdp1 'preferentially' promotes TLR-mediated production of type 1 interferon publication-title: Nat Immunol doi: 10.1038/ni.1742 – volume: 367 start-page: 97 year: 2002 end-page: 105 ident: CR45 article-title: Signal transducers and activators of transcription 3 (STAT3) inhibits transcription of the inducible nitric oxide synthase gene by interacting with nuclear factor kappaB publication-title: Biochem J doi: 10.1042/bj20020588 – volume: 420 start-page: 846 year: 2002 end-page: 852 ident: CR2 article-title: Points of control in inflammation publication-title: Nature doi: 10.1038/nature01320 – volume: 44 start-page: 126 year: 2008 end-page: 134 ident: CR39 article-title: Inhibition of lipopolysaccharide-induced nitric oxide synthesis by nicotine through S6K1-p42/44 MAPK pathway and STAT3 (Ser 727) phosphorylation in Raw 264.7 cells publication-title: Cytokine doi: 10.1016/j.cyto.2008.07.006 – volume: 154 start-page: 1558 year: 2008 end-page: 1571 ident: CR11 article-title: Acetylcholine beyond neurons: The non-neuronal cholinergic system in humans publication-title: Br J Pharmacol doi: 10.1038/bjp.2008.185 – volume: 9 start-page: 309 year: 2010 ident: CR47 article-title: Signal transducer and activator of transcription 3 activation up-regulates interleukin-6 autocrine production: a biochemical and genetic study of established cancer cell lines and clinical isolated human cancer cells publication-title: Mol Cancer doi: 10.1186/1476-4598-9-309 – volume: 17 start-page: 64 year: 2011 end-page: 70 ident: CR20 article-title: MicroRNA-124 promotes microglia quiescence and suppresses EAE by deactivating macrophages via the C/EBP-α-PU.1 pathway publication-title: Nat Med doi: 10.1038/nm.2266 – volume: 105 start-page: 11008 year: 2008 end-page: 11013 ident: CR25 article-title: Splenic nerve is required for cholinergic antiinflammatory pathway control of TNF in endotoxemia publication-title: Proc Natl Acad Sci USA doi: 10.1073/pnas.0803237105 – volume: 67 start-page: 129 year: 2011 end-page: 139 ident: CR15 article-title: Biological functions of microRNAs: a review publication-title: J Physiol Biochem doi: 10.1007/s13105-010-0050-6 – volume: 6 start-page: 844 year: 2005 end-page: 851 ident: CR41 article-title: Stimulation of the vagus nerve attenuates macrophage activation by activating the Jak2-STAT3 signaling pathway publication-title: Nat Immunol doi: 10.1038/ni1229 – volume: 176 start-page: 721 year: 2006 end-page: 725 ident: CR27 article-title: Tissue inhibitor of metalloproteinase 3 regulates TNF-dependent systemic inflammation publication-title: J Immunol doi: 10.4049/jimmunol.176.2.721 – volume: 9 start-page: 103 year: 2000 end-page: 111 ident: CR31 article-title: Anti-TNF agents in crohn's disease publication-title: Expert Opin Investig Drugs doi: 10.1517/13543784.9.1.103 – volume: 15 start-page: 283 year: 2009 end-page: 293 ident: CR46 article-title: Persistently activated Stat3 maintains constitutive NF-kappaB activity in tumors publication-title: Cancer Cell doi: 10.1016/j.ccr.2009.02.015 – volume: 454 start-page: 428 year: 2008 end-page: 435 ident: CR1 article-title: Origin and physiological roles of inflammation publication-title: Nature doi: 10.1038/nature07201 – volume: 385 start-page: 733 year: 1997 end-page: 736 ident: CR26 article-title: Cloning of a disintegrin metalloproteinase that processes precursor tumour-necrosis factor-alpha publication-title: Nature doi: 10.1038/385733a0 – volume: 297 start-page: C1294 year: 2009 end-page: C1306 ident: CR40 article-title: Cholinergic agonists regulate JAK2/STAT3 signaling to suppress endothelial cell activation publication-title: Am J Physiol Cell Physiol doi: 10.1152/ajpcell.00160.2009 – volume: 30 start-page: 313 year: 2012 end-page: 335 ident: CR34 article-title: Reflex principles of immunological homeostasis publication-title: Annu Rev Immunol doi: 10.1146/annurev-immunol-020711-075015 – volume: 430 start-page: 218 year: 2004 end-page: 222 ident: CR37 article-title: Regulation of Toll/IL-1-receptor-mediated gene expression by the inducible nuclear protein IkappaBzeta publication-title: Nature doi: 10.1038/nature02738 – volume: 27 start-page: 10578 year: 2007 end-page: 10587 ident: CR13 article-title: Broad-spectrum efficacy across cognitive domains by alpha7 nicotinic acetylcholine receptor agonism correlates with activation of ERK/2 and CREB phosphorylation pathways publication-title: J Neurosci doi: 10.1523/JNEUROSCI.2444-07.2007 – volume: 147 start-page: 1233 year: 2011 end-page: 1247 ident: CR49 article-title: An HNF4α-miRNA inflammatory feedback circuit regulates hepatocellular oncogenesis publication-title: Cell doi: 10.1016/j.cell.2011.10.043 – volume: 334 start-page: 98 year: 2011 end-page: 101 ident: CR6 article-title: Acetylcholine-synthesizing T cells relay neural signals in a vagus nerve circuit publication-title: Science doi: 10.1126/science.1209985 – volume: 405 start-page: 458 year: 2000 end-page: 462 ident: CR4 article-title: Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin publication-title: Nature doi: 10.1038/35013070 – volume: 69 start-page: 1041 year: 2006 end-page: 1047 ident: CR44 article-title: Janus kinase-signal transducer and activator of transcription mediates phosphatidic acid-induced interleukin (IL)-1beta and IL-6 production publication-title: Mol Pharmacol – volume: 28 start-page: 413 year: 2011 end-page: 416 ident: CR9 article-title: Application of alpha7 nicotinic acetylcholine receptor agonists in inflammatory diseases: an overview publication-title: Pharm Res doi: 10.1007/s11095-010-0283-7 – volume: 108 start-page: 345 year: 2013 ident: CR10 article-title: Vagal stimulation triggers peripheral vascular protection through the cholinergic anti-inflammatory pathway in a rat model of myocardial ischemia/reperfusion publication-title: Basic Res Cardiol doi: 10.1007/s00395-013-0345-1 – volume: 58 start-page: 3439 year: 2008 end-page: 3449 ident: CR19 article-title: Acetylcholine regulation of synoviocyte cytokine expression by the alpha7 nicotinic receptor publication-title: Arthritis Rheum doi: 10.1002/art.23987 – volume: 183 start-page: 2150 year: 2009 end-page: 2158 ident: CR50 article-title: MicroRNA-146a feedback inhibits RIG-I-dependent type I IFN production in macrophages by targeting TRAF6, IRAK1, and IRAK2 publication-title: J Immunol doi: 10.4049/jimmunol.0900707 – volume: 46 start-page: 1867 year: 2009 end-page: 1877 ident: CR43 article-title: STAT3 tyrosine phosphorylation is critical for interleukin 1 beta and interleukin-6 production in response to lipopolysaccharide and live bacteria publication-title: Mol Immunol doi: 10.1016/j.molimm.2009.02.018 – volume: 20 start-page: 125 year: 2002 end-page: 163 ident: CR3 article-title: Neuroendocrine regulation of immunity publication-title: Annu Rev Immunol doi: 10.1146/annurev.immunol.20.082401.104914 – volume: 30 start-page: 1746 year: 2012 end-page: 1755 ident: CR48 article-title: microRNA-124 regulates cardiomyocyte differentiation of bone marrow-derived mesenchymal stem cells via targeting STAT3 signaling publication-title: Stem Cells doi: 10.1002/stem.1154 – volume: 104 start-page: 19291 year: 2007 end-page: 19296 ident: CR16 article-title: A biochemical approach to identifying microRNA targets publication-title: Proc Natl Acad Sci USA doi: 10.1073/pnas.0709971104 – volume: 9 start-page: 514 year: 2009 end-page: 520 ident: CR21 article-title: MicroRNAs and the immune response publication-title: Curr Opin Pharmacol doi: 10.1016/j.coph.2009.05.003 – volume: 40 start-page: 2580 year: 2010 end-page: 2589 ident: CR42 article-title: Unphosphorylated STAT3 modulates α7 nicotinic receptor signaling and cytokine production in sepsis publication-title: Eur J Immunol doi: 10.1002/eji.201040540 – volume: 9 start-page: 129 year: 2011 ident: CR35 article-title: Anti-inflammatory effects of nicotine in obesity and ulcerative colitis publication-title: J Transl Med doi: 10.1186/1479-5876-9-129 – volume: 27 start-page: 605 year: 2011 end-page: 612 ident: CR38 article-title: Nicotine reduces TNF-α expression through a α7 nAChR/MyD88/NF-κb pathway in HBE16 airway epithelial cells publication-title: Cell Physiol Biochem doi: 10.1159/000329982 – volume: 179 start-page: 5082 year: 2007 end-page: 5089 ident: CR22 article-title: Modulation of mir-155 and mir-125b levels following lipopolysaccharide/TNF-alpha stimulation and their possible roles in regulating the response to endotoxin shock publication-title: J Immunol doi: 10.4049/jimmunol.179.8.5082 – volume: 78 start-page: 1 year: 2012 end-page: 8 ident: CR33 article-title: Sepsis, systemic inflammatory response, and multiple organ dysfunction: the mystery continues publication-title: Am Surg – volume: 2 start-page: 364 year: 2002 end-page: 371 ident: CR30 article-title: Development of anti-TNF therapy for rheumatoid arthritis publication-title: Nat Rev Immunol doi: 10.1038/nri802 – volume: 30 start-page: 295 year: 2012 ident: BFcr2013116_CR17 publication-title: Annu Rev Immunol doi: 10.1146/annurev-immunol-020711-075013 – volume: 421 start-page: 384 year: 2003 ident: BFcr2013116_CR14 publication-title: Nature doi: 10.1038/nature01339 – volume: 176 start-page: 721 year: 2006 ident: BFcr2013116_CR27 publication-title: J Immunol doi: 10.4049/jimmunol.176.2.721 – volume: 454 start-page: 428 year: 2008 ident: BFcr2013116_CR1 publication-title: Nature doi: 10.1038/nature07201 – volume: 27 start-page: 605 year: 2011 ident: BFcr2013116_CR38 publication-title: Cell Physiol Biochem doi: 10.1159/000329982 – volume: 8 start-page: 2019 year: 2009 ident: BFcr2013116_CR36 publication-title: Cell Cycle doi: 10.4161/cc.8.13.8816 – volume: 6 start-page: 844 year: 2005 ident: BFcr2013116_CR41 publication-title: Nat Immunol doi: 10.1038/ni1229 – volume: 27 start-page: 10578 year: 2007 ident: BFcr2013116_CR13 publication-title: J Neurosci doi: 10.1523/JNEUROSCI.2444-07.2007 – volume: 179 start-page: 2686 year: 2007 ident: BFcr2013116_CR28 publication-title: J Immunol doi: 10.4049/jimmunol.179.5.2686 – volume: 15 start-page: 283 year: 2009 ident: BFcr2013116_CR46 publication-title: Cancer Cell doi: 10.1016/j.ccr.2009.02.015 – volume: 385 start-page: 733 year: 1997 ident: BFcr2013116_CR26 publication-title: Nature doi: 10.1038/385733a0 – volume: 154 start-page: 1558 year: 2008 ident: BFcr2013116_CR11 publication-title: Br J Pharmacol doi: 10.1038/bjp.2008.185 – volume: 4 start-page: 673 year: 2005 ident: BFcr2013116_CR5 publication-title: Nat Rev Drug Discov doi: 10.1038/nrd1797 – volume: 430 start-page: 218 year: 2004 ident: BFcr2013116_CR37 publication-title: Nature doi: 10.1038/nature02738 – volume: 108 start-page: 345 year: 2013 ident: BFcr2013116_CR10 publication-title: Basic Res Cardiol doi: 10.1007/s00395-013-0345-1 – volume: 23 start-page: 421 year: 2011 ident: BFcr2013116_CR23 publication-title: Int Immunol doi: 10.1093/intimm/dxr034 – volume: 58 start-page: 3439 year: 2008 ident: BFcr2013116_CR19 publication-title: Arthritis Rheum doi: 10.1002/art.23987 – volume: 67 start-page: 129 year: 2011 ident: BFcr2013116_CR15 publication-title: J Physiol Biochem doi: 10.1007/s13105-010-0050-6 – volume: 9 start-page: 514 year: 2009 ident: BFcr2013116_CR21 publication-title: Curr Opin Pharmacol doi: 10.1016/j.coph.2009.05.003 – volume: 9 start-page: 103 year: 2000 ident: BFcr2013116_CR31 publication-title: Expert Opin Investig Drugs doi: 10.1517/13543784.9.1.103 – volume: 69 start-page: 1041 year: 2006 ident: BFcr2013116_CR44 publication-title: Mol Pharmacol doi: 10.1124/mol.105.018481 – volume: 147 start-page: 1233 year: 2011 ident: BFcr2013116_CR49 publication-title: Cell doi: 10.1016/j.cell.2011.10.043 – volume: 10 start-page: 744 year: 2009 ident: BFcr2013116_CR51 publication-title: Nat Immunol doi: 10.1038/ni.1742 – volume: 187 start-page: 718 year: 2011 ident: BFcr2013116_CR7 publication-title: J Immunol doi: 10.4049/jimmunol.1100013 – volume: 179 start-page: 5082 year: 2007 ident: BFcr2013116_CR22 publication-title: J Immunol doi: 10.4049/jimmunol.179.8.5082 – volume: 10 start-page: 89 year: 2010 ident: BFcr2013116_CR32 publication-title: Nat Rev Immunol doi: 10.1038/nri2691 – volume: 367 start-page: 97 year: 2002 ident: BFcr2013116_CR45 publication-title: Biochem J doi: 10.1042/bj20020588 – volume: 23 start-page: 9024 year: 2003 ident: BFcr2013116_CR12 publication-title: J Neurosci doi: 10.1523/JNEUROSCI.23-27-09024.2003 – volume: 104 start-page: 19291 year: 2007 ident: BFcr2013116_CR16 publication-title: Proc Natl Acad Sci USA doi: 10.1073/pnas.0709971104 – volume: 44 start-page: 126 year: 2008 ident: BFcr2013116_CR39 publication-title: Cytokine doi: 10.1016/j.cyto.2008.07.006 – volume: 40 start-page: 2580 year: 2010 ident: BFcr2013116_CR42 publication-title: Eur J Immunol doi: 10.1002/eji.201040540 – volume: 28 start-page: 413 year: 2011 ident: BFcr2013116_CR9 publication-title: Pharm Res doi: 10.1007/s11095-010-0283-7 – volume: 10 start-page: 1216 year: 2004 ident: BFcr2013116_CR8 publication-title: Nat Med doi: 10.1038/nm1124 – volume: 17 start-page: 64 year: 2011 ident: BFcr2013116_CR20 publication-title: Nat Med doi: 10.1038/nm.2266 – volume: 348 start-page: 138 year: 2003 ident: BFcr2013116_CR29 publication-title: N Engl J Med doi: 10.1056/NEJMra021333 – volume: 78 start-page: 1 year: 2012 ident: BFcr2013116_CR33 publication-title: Am Surg doi: 10.1177/000313481207800102 – volume: 30 start-page: 313 year: 2012 ident: BFcr2013116_CR34 publication-title: Annu Rev Immunol doi: 10.1146/annurev-immunol-020711-075015 – volume: 105 start-page: 11008 year: 2008 ident: BFcr2013116_CR25 publication-title: Proc Natl Acad Sci USA doi: 10.1073/pnas.0803237105 – volume: 20 start-page: 125 year: 2002 ident: BFcr2013116_CR3 publication-title: Annu Rev Immunol doi: 10.1146/annurev.immunol.20.082401.104914 – volume: 2 start-page: 364 year: 2002 ident: BFcr2013116_CR30 publication-title: Nat Rev Immunol doi: 10.1038/nri802 – volume: 334 start-page: 98 year: 2011 ident: BFcr2013116_CR6 publication-title: Science doi: 10.1126/science.1209985 – volume: 297 start-page: C1294 year: 2009 ident: BFcr2013116_CR40 publication-title: Am J Physiol Cell Physiol doi: 10.1152/ajpcell.00160.2009 – volume: 460 start-page: 529 year: 2009 ident: BFcr2013116_CR18 publication-title: Nature doi: 10.1038/nature08199 – volume: 9 start-page: 129 year: 2011 ident: BFcr2013116_CR35 publication-title: J Transl Med doi: 10.1186/1479-5876-9-129 – volume: 9 start-page: 309 year: 2010 ident: BFcr2013116_CR47 publication-title: Mol Cancer doi: 10.1186/1476-4598-9-309 – volume: 46 start-page: 1867 year: 2009 ident: BFcr2013116_CR43 publication-title: Mol Immunol doi: 10.1016/j.molimm.2009.02.018 – volume: 183 start-page: 2150 year: 2009 ident: BFcr2013116_CR50 publication-title: J Immunol doi: 10.4049/jimmunol.0900707 – volume: 405 start-page: 458 year: 2000 ident: BFcr2013116_CR4 publication-title: Nature doi: 10.1038/35013070 – volume: 420 start-page: 846 year: 2002 ident: BFcr2013116_CR2 publication-title: Nature doi: 10.1038/nature01320 – volume: 203 start-page: 1623 year: 2006 ident: BFcr2013116_CR24 publication-title: J Exp Med doi: 10.1084/jem.20052362 – volume: 30 start-page: 1746 year: 2012 ident: BFcr2013116_CR48 publication-title: Stem Cells doi: 10.1002/stem.1154 – reference: 16785311 - J Exp Med. 2006 Jul 10;203(7):1623-8 – reference: 19299019 - Mol Immunol. 2009 May;46(8-9):1867-77 – reference: 17898229 - J Neurosci. 2007 Sep 26;27(39):10578-87 – reference: 12519925 - N Engl J Med. 2003 Jan 9;348(2):138-50 – reference: 20981514 - J Physiol Biochem. 2011 Mar;67(1):129-39 – reference: 20081871 - Nat Rev Immunol. 2010 Feb;10(2):89-102 – reference: 22273282 - Am Surg. 2012 Jan;78(1):1-8 – reference: 16354768 - Mol Pharmacol. 2006 Mar;69(3):1041-7 – reference: 21666060 - J Immunol. 2011 Jul 15;187(2):718-25 – reference: 12057007 - Biochem J. 2002 Oct 1;367(Pt 1):97-105 – reference: 19741199 - Am J Physiol Cell Physiol. 2009 Nov;297(5):C1294-306 – reference: 22224768 - Annu Rev Immunol. 2012;30:313-35 – reference: 11861600 - Annu Rev Immunol. 2002;20:125-63 – reference: 15241416 - Nature. 2004 Jul 8;430(6996):218-22 – reference: 15502843 - Nat Med. 2004 Nov;10(11):1216-21 – reference: 19525145 - Curr Opin Pharmacol. 2009 Aug;9(4):514-20 – reference: 19502795 - Cell Cycle. 2009 Jul 1;8(13):2019-23 – reference: 23519622 - Basic Res Cardiol. 2013 May;108(3):345 – reference: 18042700 - Proc Natl Acad Sci U S A. 2007 Dec 4;104(49):19291-6 – reference: 18500366 - Br J Pharmacol. 2008 Aug;154(8):1558-71 – reference: 21691078 - Cell Physiol Biochem. 2011;27(5):605-12 – reference: 22224773 - Annu Rev Immunol. 2012;30:295-312 – reference: 19345327 - Cancer Cell. 2009 Apr 7;15(4):283-93 – reference: 21131957 - Nat Med. 2011 Jan;17(1):64-70 – reference: 20706987 - Eur J Immunol. 2010 Sep;40(9):2580-9 – reference: 24018376 - Cell Res. 2013 Nov;23(11):1249-50 – reference: 21921156 - Science. 2011 Oct 7;334(6052):98-101 – reference: 9034191 - Nature. 1997 Feb 20;385(6618):733-6 – reference: 17911593 - J Immunol. 2007 Oct 15;179(8):5082-9 – reference: 19626115 - Nature. 2009 Jul 23;460(7254):529-33 – reference: 12490957 - Nature. 2002 Dec 19-26;420(6917):846-52 – reference: 21122157 - Mol Cancer. 2010;9:309 – reference: 14534236 - J Neurosci. 2003 Oct 8;23(27):9024-31 – reference: 18723372 - Cytokine. 2008 Oct;44(1):126-34 – reference: 11060664 - Expert Opin Investig Drugs. 2000 Jan;9(1):103-11 – reference: 12033742 - Nat Rev Immunol. 2002 May;2(5):364-71 – reference: 18975306 - Arthritis Rheum. 2008 Nov;58(11):3439-49 – reference: 12508119 - Nature. 2003 Jan 23;421(6921):384-8 – reference: 16056392 - Nat Rev Drug Discov. 2005 Aug;4(8):673-84 – reference: 22696253 - Stem Cells. 2012 Aug;30(8):1746-55 – reference: 21810260 - J Transl Med. 2011;9:129 – reference: 18669662 - Proc Natl Acad Sci U S A. 2008 Aug 5;105(31):11008-13 – reference: 19483718 - Nat Immunol. 2009 Jul;10(7):744-52 – reference: 16393953 - J Immunol. 2006 Jan 15;176(2):721-5 – reference: 19596990 - J Immunol. 2009 Aug 1;183(3):2150-8 – reference: 10839541 - Nature. 2000 May 25;405(6785):458-62 – reference: 20859658 - Pharm Res. 2011 Feb;28(2):413-6 – reference: 18650913 - Nature. 2008 Jul 24;454(7203):428-35 – reference: 21652514 - Int Immunol. 2011 Jul;23(7):421-5 – reference: 17709479 - J Immunol. 2007 Sep 1;179(5):2686-9 – reference: 22153071 - Cell. 2011 Dec 9;147(6):1233-47 – reference: 16025117 - Nat Immunol. 2005 Aug;6(8):844-51 |
| SSID | ssj0025451 |
| Score | 2.5279498 |
| Snippet | The vagus nerve can control inflammatory response through a 'cholinergic anti-inflammatory pathway', which is mediated by the α7-nicotinic acetylcholine... The vagus nerve can control inflammatory response through a 'cholinergic anti-inflammatory pathway', which is mediated by the α7-nicotinic acetylcholine... The vagus nerve can control inflammatory response through a 'cholinergic anti-inflammatory pathway', which is mediated by the alpha 7-nicotinic acetylcholine... |
| SourceID | pubmedcentral proquest pubmed crossref springer chongqing |
| SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 1270 |
| SubjectTerms | 631/250/127 631/250/2504/342 631/250/256 631/337/384/331 Acetylcholine receptors ADAM Proteins - metabolism ADAM17 Protein alpha7 Nicotinic Acetylcholine Receptor - metabolism Animals Biomedical and Life Sciences Cell Biology Cells, Cultured Cholinergic Neurons - metabolism Cytokines - biosynthesis Cytokines - genetics Cytokines - secretion HEK293 Cells Humans Interleukin-6 - biosynthesis Interleukin-6 - genetics Life Sciences Lipopolysaccharides - antagonists & inhibitors Lipopolysaccharides - pharmacology Macrophages - metabolism Mice Mice, Inbred BALB C Mice, Inbred C57BL MicroRNAs - metabolism Original original-article Sepsis - chemically induced Sepsis - genetics Sepsis - metabolism Sepsis - pathology siRNA STAT3 STAT3 Transcription Factor - metabolism TNF-α Transcription, Genetic Tumor Necrosis Factor-alpha - biosynthesis Tumor Necrosis Factor-alpha - genetics 乙酰胆碱受体 介导 抗炎作用 细胞因子 胆碱能 |
| Title | MicroRNA-124 mediates the cholinergic anti-inflammatory action through inhibiting the production of pro-inflammatory cytokines |
| URI | http://lib.cqvip.com/qk/85240X/201311/47769860.html https://link.springer.com/article/10.1038/cr.2013.116 https://www.ncbi.nlm.nih.gov/pubmed/23979021 https://www.proquest.com/docview/1448240721 https://www.proquest.com/docview/1449282100 https://www.proquest.com/docview/1464503031 https://pubmed.ncbi.nlm.nih.gov/PMC3817544 |
| Volume | 23 |
| WOSCitedRecordID | wos000326683600009&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVPQU databaseName: Biological Science Database customDbUrl: eissn: 1748-7838 dateEnd: 20181231 omitProxy: false ssIdentifier: ssj0025451 issn: 1001-0602 databaseCode: M7P dateStart: 20000301 isFulltext: true titleUrlDefault: http://search.proquest.com/biologicalscijournals providerName: ProQuest – providerCode: PRVPQU databaseName: Health & Medical Collection customDbUrl: eissn: 1748-7838 dateEnd: 20181231 omitProxy: false ssIdentifier: ssj0025451 issn: 1001-0602 databaseCode: 7X7 dateStart: 20000301 isFulltext: true titleUrlDefault: https://search.proquest.com/healthcomplete providerName: ProQuest – providerCode: PRVPQU databaseName: ProQuest Central customDbUrl: eissn: 1748-7838 dateEnd: 20181231 omitProxy: false ssIdentifier: ssj0025451 issn: 1001-0602 databaseCode: BENPR dateStart: 20000301 isFulltext: true titleUrlDefault: https://www.proquest.com/central providerName: ProQuest |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lb9RADLZoC1IvPMqjW8oqSOWCFDWTTDKZEyqoFRdWqwqkvUXzChsVku3uFqkXfjv25AHLol64RIrGeYzs8dhj-zPAiZVca6NZmCdOhVyVNpR5WoZMlzxXMtI2sr7ZhJhM8tlMTrsDt1WXVtnrRK-obWPojPwUDf-8RfN6t7gOqWsURVe7Fho7sEcoCbFP3ZsODhdaB97h8mlDGWXyHLRl5vmpISxQlqDG8KgK86b-eo17xebutGVybmdO_hU-9bvSxaP_nc9jeNjZo8FZK0BP4J6rD-BB26Hy9in8_EQJe5eTsxB36MCXmaBtGqDVGJDe9JWDlQmQPVWIsori9d2H7YO2XiLo2gAFVT2vdEUp1v7ZRYszSxRNSXebD5vbdXNF-fjP4MvF-ecPH8OuZUNoUsHWoRKlcI6nWhpm4zhysoxtwpjJXCa1Y6Vy6ENZk2qWKLQkJY7aWGWO8JEVGpvPYbduancIgVHOxhEXkeaGW850XMZJ6lKDImRKl47gaGBbsWihOQouRCbzLBrB256PhenAzqnnxrfCB92TvDDLggQAPaBsBCcDcf-if5Id95wsuoW-Kn6zcQSvh2FcohR3UbVrbjyNRM8WxfAumoynqHATfM-LVsaGf4kp9hrRF8SG9A0EBBG-OVJXcw8VTviLKecjeNPL6R-_vj3Fo7un-BL2ibItxTyG3fXyxr2C--bHulotx7AjZsJf8zHsvT-fTC_Hfj3-AvhdPpw |
| linkProvider | ProQuest |
| linkToHtml | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1Lb9QwELaqAoILj_JKKRCk9oIUNXacOD4gVAFVq7YrhIq0txA_wkZAst3dgvbCT-I3MmMnW5ZFvfXAMfI4iXe_Gc_EM98Qsm0kV0orGuWJLSNeViaSeVpFVFU8L2WsTGxcswkxGOTDoXy_Rn71tTCYVtnbRGeoTavxG_kuOP65Z_N6PT6LsGsUnq72LTQ8LI7s_AeEbNNXh2_h_91hbP_d6ZuDqOsqEOlU0FlUikpYy1MlNTWMxVZWzCSU6sxmUllalRbcfKNTRZMSnB0Jo4aVmUUK31Ii0QGY_GtgxwUGe2J4EeCBN-ICPJemlGHm0IYva893NXKP0gQslGNxGLXN5zPYm5Z3wxUXdzVT86_jWrcL7t_5336_u-R252-He15B7pE122yQG74D5_w--XmCCYkfBnsReCChK6MB3zsErzjEfcFVRtY6BPjVEegiqM83l5YQ-nqQsGtzFNbNqFY1ppC7uWPPo4sSbYVXy5P1fNZ-wXqDB-TjlSz-IVlv2sY-JqEurWExF7HimhtOFatYktpUg4royqYB2VzApBh76pGCC5HJPIsD8rLHTaE7MnfsKfK1cEkFSV7oSYGAgwgvC8j2Qri_0T_FtnrkFJ0hmxYXsAnIi8UwmCA8Vyob2547GQmRO8D-MpmMp7ChJHCfRx7Ti3dheLYc4xPEEtoXAkiBvjzS1CNHhY78kinnAdnp9eKPV19d4ublS3xObh6cnhwXx4eDoyfkFs7yZadbZH02ObdPyXX9fVZPJ8-c3ofk01Urym-ZZpj3 |
| linkToPdf | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1Lb9NAEB5VKSAuPAoFlwJGai9IVvxYP_aAUKGNqApWVIHUm_E-TCzATpMUlAs_jF_HzPoBIai3HjhaO2t7k5nZb7wz3wDsKc6EkMJzkkDnDssL5fAkLBxPFCzJuSuUq0yziThNk7MzPt6An10tDKVVdj7ROGpVS_pGPkTgnzRsXsOiTYsYH45eTs8d6iBFJ61dO41GRU708juGb_MXx4f4X-_7_ujo_es3TtthwJFh7C2cPC5irVkouPSU77uaF74KPE9GOuJCe0WuEfIrGQovyBH4cBxVfh5povPNOZEeoPvfjBFksAFsvjpKx6d9uIfYxIR7JmkpojyirabIPRlKYiL1AvRXhtNhUlefznGnWt0b1wDvet7mX4e3Zk8c3f6ff807cKtF4vZBYzp3YUNXW3C96c25vAc_3lGq4ml64CA2sU2BDaJyG_GyTTuGqZkspY2KWTpopWhYX03Cgt1UithtAyS7rCalKCm53MydNgy7JFEXdLU6WS4X9WeqRLgPH65k8dswqOpKPwRb5lr5LotdwSRTzBN-4QehDiUajyx0aMFOrzLZtCElyVgcRzyJXAuedzqUyZbmnbqNfMlMukGQZHKWkfJh7BdZsNcLdzf6p9hup0VZ6-Lm2W8VsuBZP4zOiU6c8krXF0aGY0yPJnCZTMRC3GoCvM-DRr_7d_Hp1NmlJ8Qrmt8LEDn66khVTgxJOjFPhoxZsN_ZyB-vvr7EncuX-BRuoH1kb4_Tk0dwkyY19ai7MFjMLvRjuCa_Lcr57EnrBGz4eNWW8gtIcqMX |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=MicroRNA-124+mediates+the+cholinergic+anti-inflammatory+action+through+inhibiting+the+production+of+pro-inflammatory+cytokines&rft.jtitle=Cell+research&rft.au=Sun%2C+Yang&rft.au=Li%2C+Qi&rft.au=Gui%2C+Huan&rft.au=Xu%2C+Dong-Ping&rft.date=2013-11-01&rft.issn=1748-7838&rft.eissn=1748-7838&rft.volume=23&rft.issue=11&rft.spage=1270&rft_id=info:doi/10.1038%2Fcr.2013.116&rft.externalDBID=NO_FULL_TEXT |
| thumbnail_s | http://cvtisr.summon.serialssolutions.com/2.0.0/image/custom?url=http%3A%2F%2Fimage.cqvip.com%2Fvip1000%2Fqk%2F85240X%2F85240X.jpg |